Oncology Drug Development | Who We Are | Teon Therapeutics
We are on a relentless mission to push the boundaries of science in cancer care as we know it today. We are guided by the goal to ensure no patient with cancer ever hears the words, “there are no more options for you.”. We are guided by our shared experiences of serving patients with cancer, including our own cancer battles, those of our loved ones, and patients we’ve helped and served along the way. We are helping cancer patients spend time on what matters most by targeting untapped metabolic signaling pathways to restore anti-tumor immunity and provide better outcomes for patients. We are on a relentless mission to push the boundaries of science in cancer care as we know it. And we’re committed to developing and delivering important medicines to patients. Our highly accomplished leadership team is comprised of experts in tumor metabolism, cell signaling and GPCR therapeutic design. Targeting unexploited metabolic pathways backed by validated science and an initial focus on maximizing the potential benefits of GPCRs to address difficult-to-treat cancers.
Verified
Featured News | Teon Therapeutics
Teon Therapeutics: Antagonizing Metabolic Pathways in the Tumor Microenvironment | The Bio Report: Restoring Immune Activity While Suppressing Cancer Proliferation | Chutes & Ladders—Janssen’s US oncology lead jumps to Teon as CEO | Teon appoints former Janssen exec as CEO | Privacy Overview
View all products
Keywords
Industries
Teon Therapeutics Announces FDA Acceptance of IND Application for Novel, Oral Immune Checkpoint Inhibitor, TT-816 | Teon Therapeutics
SAN FRANCISCO, June 1, 2022 – Teon Therapeutics (Teon), a clinical-stage biopharmaceutical company targeting metabolic signaling pathways and pioneering the
Where is Teon Therapeutics located?
The company Teon Therapeutics is located in Temecula, California, United States. It's worth noting that the company may has more corporate locations
How many employees does Teon Therapeutics approximately have?
As of the latest available information Teon Therapeutics has around 11-50 employees worldwide.
When was Teon Therapeutics founded?
Teon Therapeutics was founded in 2017
In which industries does Teon Therapeutics mainly work?
The company Teon Therapeutics has it's main focus in the industries of Biotechnology, Health Care, Science and Engineering
Teclison Limited
United States
1-10 Employees
2015
G1 Therapeutics
United States
51-100 Employees
2008
858 Therapeutics
United States
11-50 Employees
2019
Cue Biopharma
United States
11-50 Employees
2014
Legend Biotech
United States
101-250 Employees
2014
Scorpion Therapeutics
United States
11-50 Employees
2020
Agenus
United States
251-500 Employees
1994
M2Gen
United States
51-100 Employees
2006
Topics which have been searched by others and may be interesting for you: